Please Enable Cookies

www.laserfocusworld.com is using a security service for protection against online attacks. This process is automatic. You will be redirected once the validation process is complete.

Recent Quotes
My Watchlist
Indicators
Industrial Laser Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Chugai Pharmaceutica ADR (OP: CHGCY )

23.64 +0.04 (+0.17%)
Streaming Delayed Price Updated: 3:59 PM EDT, Oct 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 229,106
Open 22.51
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 23.60
Today's Range 22.51 - 24.22
52wk Range 14.10 - 26.00
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
OZEM ETF: 7 Things to Know About the New Roundhill GLP-1 & Weight Loss ETF
As weight loss drugs are gaining popularity Roundhill GLP 1 And Weight Loss ETF (OZEM) has launched as anew way to invest in them. 
Via InvestorPlace
Topics ETFs
Week In Review: LianBio To Close Operations; Will Pay $528 Million To Shareholders
LianBio, a Princeton-Shanghai biotech, has decided to call it quits. LianBio plans to stop all of its operations by the end of 2024, and it will distribute a $4.80 dividend/share ($528 million) to its... 
Via Talk Markets

Performance

YTD
+26.42%
+26.42%
1 Month
-1.66%
-1.66%
3 Month
+24.75%
+24.75%
6 Month
+42.07%
+42.07%
1 Year
+57.29%
+57.29%

More News

Read More
3 Stocks To Consider With Earnings Approaching
Via Talk Markets
5 Diverse Medical Stocks To Buy For 2023 And Beyond
Via Talk Markets
The Daily Biotech Pulse: AbbVie's Rinvoq Gets Label Expansion, AstraZeneca COVID Antibody Cocktail Authorized By UK Regulator, Stealth Touts Positive Data
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.